Using the Sten C1000 system for repairing ureteral strictures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study evaluates the safety and efficacy of the Sten® Laparoendoscopic Surgical System C1000 for performing benign ureteral reconstruction surgery. It is a single-arm, open-label, prospective, non-randomized cohort study involving 50 patients who require upper urinary tract repair. Participants will be monitored for surgical success rates, operating times, blood loss, and postoperative pain scores. The study aims to provide insights into the effectiveness of this robotic surgical system in treating ureteral strictures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* (1) Patients aged ≥18 years and ≤80 years, male or female; (2) Patients who need to undergo upper urinary tract repair surgery; (3) Patients who are suitable for ureteral reconstruction as confirmed by the investigator; (4) Subjects who voluntarily participate in the clinical trial and agree or whose guardians agree and sign the informed consent form; (5) Willing to cooperate and complete the trial follow-up and related examinations.

Exclusion Criteria:

* (1) Presence of severe drug/imaging contrast allergy; (2) Patients with a history of pelvic/abdominal surgery and assessed for extensive severe adhesions; (3) Those with a previous history of other malignancies and judged by the investigator to be unsuitable for enrollment; (4) Diseases that are not expected to tolerate pneumoperitoneum or prolonged head-down-foot-up position, or diseases that do not allow intraoperative positioning, such as spinal deformity or ankylosing spondylitis; (5) Those with serious comorbidities (heart, lung, liver, brain, kidney and other diseases) and those who are physically weak and cannot tolerate general anesthesia or surgery; (6) Those with serious bleeding tendency or coagulation disorders; (7) Patients who have been using anticoagulant or antiplatelet aggregating drugs for a long time, or those who have stopped using anticoagulant or antiplatelet aggregating drugs for less than 1 week before surgery (except for the prophylactic use of low molecular heparin before surgery); (8) Patients with active infectious diseases or other severe non-infectious infections; (9) Those who are positive for Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antigen (Hepatitis B) or Hepatitis C Surface Antigen (Hepatitis C).

Hepatitis B Surface Antigen (HbsAg)-positive, Hepatitis C Virus (HCV)-positive, and syphilis-positive patients; (10) Persons with severe allergies, suspected or confirmed alcohol, drug or drug addiction; (11) Those with a history of epilepsy or psychosis or with cognitive impairment; (12) Women who are pregnant, breastfeeding, or planning to become pregnant during the trial, or male or female patients who do not wish to use barrier contraception during the trial; (13) Participation in any other clinical trial (except non-interventional trials) within 3 months prior to signing the informed consent form, planning to undergo any other major surgical procedure during the trial, or inability to recover from the side effects of a previous procedure; (14) Any other circumstances that the investigator considers inappropriate for participation in this clinical trial.

Where it's running

• Peking University First Hospital
  Beijing, Beijing Municipality, China Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term safety of UAS-assisted vs sheathless RIRS in adults with kidney stones

  This study tests whether using a ureteral access sheath during the initial RIRS affects long-term safety and outcomes in adults with kidney stones ≤20 mm.

  Recruiting Al-Azhar University · Cairo · NCT07767773

• Shear wave elastography to distinguish obstructive from pregnancy-related hydronephrosis

  We will test whether a painless ultrasound method called shear wave elastography can tell if hydronephrosis in pregnant women with loin pain is due to obstruction or a normal pregnancy change.

  Recruiting Beni-Suef University · Banī Suwayf, Beni Suef Governorate · NCT07547891

• Optilume drug-coated balloon for treating ureteric (ureteral) strictures

  This will try a drug-coated balloon called Optilume to open short (≤4.0 cm) ureteral strictures in adults who have two working kidneys.

  Recruiting at 7 sites Urotronic Inc. · Orange, California and 6 other locations · NCT07020520

• Assessing the impact of ureteral rest duration before surgery for ureteral stricture

  This study is trying to see if the length of time a ureter is rested before surgery can affect how long the ureteral strictures are in adults who are about to have surgery for this condition.

  Recruiting Northwestern University · Chicago, Illinois · NCT06384079

• Two thin Percuflex polyurethane stents versus one larger 8Fr silicone stent for malignant ureteral obstruction

  The trial will try placing two 6Fr Percuflex polyurethane stents side-by-side versus a single large 8Fr silicone stent in people with malignant ureteral obstruction to see which approach fails less often and how they affect comfort, quality of life, and survival.

  Recruiting at 2 sites Rabin Medical Center · Petah Tikva and 1 other locations · NCT05992363

• Using a self-expanding ureteral stent to treat difficult ureteral strictures

  This study is testing whether a special stent can help people with tough ureteral strictures feel better and avoid complications over time.

  Recruiting En Chu Kong Hospital · New Taipei City · NCT05455307

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.